Pregabalin
Also known as: Lyrica · Pregabalin Viatris Pharma (previously Pregabalin Pfizer) · Pregabalin Sandoz · Pregabalin Viatris (previously Pregabalin Mylan) · Pregabalin Zentiva · Pregabalin Accord · Pregabalin Extended Release
General information only. Anpheros does not diagnose and does not recommend treatment. Talk to a doctor or pharmacist about your situation. In an emergency, call 112 (or your local emergency number).
In short
In the European Union, Pregabalin is indicated for the treatment of peripheral and central neuropathic pain, generalised anxiety disorder, and as adjunctive therapy for partial seizures with or without secondary generalisation in adults. In the United States, Pregabalin is indicated for the management of fibromyalgia, postherpetic neuralgia, neuropathic pain associated with diabetic peripheral neuropathy, and neuropathic pain associated with spinal cord injury. It is also indicated in the United States as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older. Pregabalin is listed by the cited source as having an approved use for epilepsy.
From: Source: European Medicines Agency (EMA), Lyrica — EPAR, 13/10/2026. © European Medicines Agency. · Source: European Medicines Agency (EMA), Pregabalin Viatris Pharma (previously Pregabalin Pfizer) — EPAR, 24/09/2026. © European Medicines Agency. · Data provided by the U.S. Food and Drug Administration. · Source: European Medicines Agency (EMA) — EPAR. © European Medicines Agency.
AI-generated summary of the sources cited on this page, checked automatically against them. Not reviewed by a clinician; not medical advice.
Codes
- RxNorm
- 187832 pregabalin
- EMA
- EMEA/H/C/000546, EMEA/H/C/003880, EMEA/H/C/004010, EMEA/H/C/004078, EMEA/H/C/003900, EMEA/H/C/004024
Official indications
Quoted unchanged from official product information, in English. Listed alphabetically by product, not ranked.
EMA (EU) Lyrica
Neuropathic pain Lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. Epilepsy Lyrica is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. Generalised anxiety disorder Lyrica is indicated for the treatment of generalised anxiety disorder (GAD) in adults.
Source: European Medicines Agency (EMA), Lyrica — EPAR, 13/10/2026. © European Medicines Agency.
Document date: 13/10/2026 · Official document →
FDA (USA) Pregabalin
1 INDICATIONS AND USAGE Pregabalin is indicated for: • Management of neuropathic pain associated with diabetic peripheral neuropathy • Management of postherpetic neuralgia • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older • Management of fibromyalgia • Management of neuropathic pain associated with spinal cord injury Pregabalin is indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ) Postherpetic neuralgia (PHN) ( 1 ) Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older ( 1 ) Fibromyalgia ( 1 ) Neuropathic pain associated with spinal cord injury ( 1 )
Data provided by the U.S. Food and Drug Administration.
Document date: 20260814 · Official document →
EMA (EU) Pregabalin Viatris Pharma (previously Pregabalin Pfizer)
Neuropathic painPregabalin Viatris Pharma is indicated for the treatment of peripheral and central neuropathic pain in adults. Epilepsy Pregabalin Viatris Pharma is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. Generalised Anxiety Disorder Pregabalin Viatris Pharma is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Source: European Medicines Agency (EMA), Pregabalin Viatris Pharma (previously Pregabalin Pfizer) — EPAR, 24/09/2026. © European Medicines Agency.
Document date: 24/09/2026 · Official document →
Related terms in the cited sources
Has an official indication for
- Epilepsy Condition
In alphabetical order.
Other treatments A–Z
What people report
Not enough data yet. Anonymous counts appear here only for groups of at least 20 people who agreed to share them.
External resources
Questions
What is Pregabalin approved for in the European Union?
Neuropathic pain Lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. Epilepsy Lyrica is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. Generalised anxiety disorder Lyrica is indicated for the treatment of generalised anxiety disorder (GAD) in adults. (Source: European Medicines Agency (EMA), Lyrica — EPAR, 13/10/2026. © European Medicines Agency.)
Sources and attribution
- Source: European Medicines Agency (EMA) — EPAR. © European Medicines Agency.
- Data provided by the U.S. Food and Drug Administration.
- Names other than the official source titles: Anpheros translations and plain-language names, made with AI assistance and checked automatically; the source names are in English.
- This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
- Source: European Medicines Agency (EMA), Lyrica — EPAR, 13/10/2026. © European Medicines Agency.
- Source: European Medicines Agency (EMA), Pregabalin Viatris Pharma (previously Pregabalin Pfizer) — EPAR, 24/09/2026. © European Medicines Agency.
Anpheros Search catalog 2026.10.5, published 17 October 2026. About the data →
About this page. This page brings together public information from official sources, each cited where it is used. It is not medical advice, it is not a diagnosis, and it does not tell you which treatment to take.
Treatments. Indications are quoted unchanged from official product information (European Medicines Agency, U.S. Food and Drug Administration). They describe what a medicine is approved for, not whether it is right for you. Approved uses can differ between countries. Always read the package leaflet and follow your doctor's or pharmacist's advice.
What people report. Figures marked "reported by Anpheros users" are anonymous counts from at least 20 people who agreed to share them. They show what people report, not what works, and they are not clinical evidence.
Links between terms. "May be associated with" means the link appears in a cited source. It does not mean you have that condition.
In an emergency, call 112 (or your local emergency number). Do not delay seeking medical help because of something you read here.